News
Also: Telehealth startup Antidote Health and fertility tech company Alife Health both raise $22 million.
A Nature article outlines the digital health approaches of nine countries around the world.
The company announced a deal with Indegene to launch Regulora, its recently FDA-approved prescription digital therapeutic for treating abdominal pain associated with IBS.
The app has correctly detected COVID-19 in 92% of infected participants of a clinical trial.
The device, which is not yet cleared by the FDA, alerts bystanders to a potential cardiac event nearby and guides them to the scene.
The company plans to use the money to build out its care coordination staff as well as its sales and marketing teams.
As part of the agreement, SoftBank will research market opportunities for the digital therapeutic, and it can negotiate an exclusive commercialization deal in Japan.
New research from JAMA finds ICBT non-inferior to traditional therapy.
Also, Israeli startup Well-Beat teams with UST to launch digital patient engagement solution.
HIMSS22
During a discussion at HIMSS22, panelists discuss the health challenges of a long mission to Mars and how new interfaces could keep astronauts safe.